Data / Drug companies / Ramipril
Ramipril: 19 companies and 69 products in the FDA NDC directory
Ramipril is listed in the FDA National Drug Code Directory by 19 companies, with 69 products in commercial distribution. 69 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on April 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 19
- Products
- 69
- Generic (ANDA) products
- 69 (100.0%)
- Application numbers
- 6
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list ramipril
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 7 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| Northwind Health Company, LLC | 7 | capsule | Generic drugs (ANDA) | April 27, 2023 |
| Aurobindo Pharma Limited | 4 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| BluePoint Laboratories | 4 | capsule | Generic drugs (ANDA) | February 28, 2020 |
| Bryant Ranch Prepack | 4 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| Chartwell RX, LLC | 4 | capsule | Generic drugs (ANDA) | August 26, 2020 |
| Exelan Pharmaceuticals Inc. | 4 | capsule | Generic drugs (ANDA) | June 18, 2008 |
| Hikma Pharmaceuticals USA Inc. | 4 | capsule | Generic drugs (ANDA) | June 18, 2008 |
| Lupin Pharmaceuticals, Inc. | 4 | capsule | Generic drugs (ANDA) | June 10, 2008 |
| Proficient Rx LP | 4 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| Rising Pharma Holdings, Inc. | 4 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| Zydus Lifesciences Limited | 4 | capsule | Generic drugs (ANDA) | November 20, 2010 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule | Generic drugs (ANDA) | November 20, 2010 |
| Golden State Medical Supply, Inc. | 3 | capsule | Generic drugs (ANDA) | July 8, 2025 |
| Remedyrepack Inc. | 3 | capsule | Generic drugs (ANDA) | April 22, 2026 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| Bryant Ranch Prepack | 1 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| NuCare Pharmaceuticals,Inc. | 1 | capsule | Generic drugs (ANDA) | June 8, 2011 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | November 20, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 69 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 69 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 69 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.